CME: Successful Strategies for Addressing Patient Safety Hot Topics - Infection Control and Antimicrobial Therapy in the era of Anti-Microbial Stewardship
ACCREDITATION EXPIRED: November 12, 2015
Activity Description / Statement of Need:
In this online CME self-learning program: The overall learning activity will focus on infection control and antimicrobial therapy in the era of antimicrobial stewardship, and the role of the physicians and allied health professions play in it.
**UPDATE: With concerns about the emergence of a "post-antibiotics era" and news of multi-drug-resistant bacterial outbreaks in Los Angeles in February, 2015, as well as many parts of the country, this topic has rarely been less timely.**
Infection control and antimicrobial therapy in the era of antimicrobial stewardship: Antimicrobial resistance is recognized as a significant, contemporary healthcare challenge. Three major societies - the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society, not only recently called for national regulations mandating multidisciplinary, antimicrobial stewardship teams, but three also stated that:
… significant knowledge deficits in the areas of antimicrobial resistance and antimicrobial stewardship are prevalent among healthcare providers in the United States. Educational programs should be developed for those in training programs as well as for all prescribing clinicians that teach about the science behind, the principles of, and the tools essential for the practice of effective antimicrobial stewardship .... It is crucial that currently practicing clinicians become proficient in these areas. In addition to ensuring that these areas are included in curricula and programs for those in training, there are a number of ways in which proficiency may be accomplished for practicing clinicians … [A]s a part of the drug-review process, pharmaceutical sponsors should include a plan to educate healthcare providers about both the optimal use of the drug and precautions that reduce the emergence of antimicrobial resistance.
The infectious disease societies state that such teams should include: a physician, a pharmacist, a clinical microbiologist, and an infection preventionist. Judicious treatment considerations aside, there must also be emphasis on prevention, as organisms whose spread can be minimized by strict adherence to infection control measures make up the majority of outbreaks in U.S. hospitals. There is recognition that the benefits of these initiatives result in: improved patient outcomes; improved patient safety; and decrease microbial resistance, and that efforts should not be limited to the inpatient setting. As it stands, poor infection control compliance remains a significant burden. This learning activity will aim to address those issues.
Agenda
➢Statistics: outbreaks and resistance
➢The evolving industry and regulatory picture: from pipeline to good manufacturing practices
➢Infection control at the systems level
• The culprit organisms (Clostridium difficile, other resistant Gram-positive and -negative, and fungal)
• A fresh look at standard precautions and beyond
➢Antimicrobial stewardship
• Stopping the culprit organisms in their tracks
• Strategies for constituting a new antimicrobial stewardship program
• Strategies for optimizing an existing antimicrobial stewardship program
➢Joint Commission National Patient Safety Goal updates and strategies for implementation and adaptation
➢How can informatics and clinical decision support help?
➢Putting it all together: best practices, summary, conclusions, and the role of the patient safety coordinator
Target Audience:
Healthcare professionals, including physicians, pharmacists, and mid-level practitioners working in acute care hospitals and other healthcare settings.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.
Release Date: November 12, 2013 -- Expiration Date: November 12, 2015
Faculty: Justin Clark, PharmD
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Describe the systems factors that play a major role in patient safety challenges related to infection prevention and control.
- Apply current National Patient Safety Goals to sample scenarios, recommending strategies for improvement.
- Develop a strategy, at the systems level, to constitute a new antimicrobial stewardship program.
- Develop a strategy, at the systems level, to refine an existing antimicrobial stewardship program.
- Describe the role that health informatics and clinical decision support may play in infection control and antimicrobial stewarship.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of ScientiaCME and The American Society of Medication Safety Officiers (ASMSO). ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
ACCREDITATION FOR THIS PROGRAM HAS EXPIRED. NO CERTIFICATES WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As an provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Faculty Disclosure: Justin Clark, PharmD reports that he has no relevant financial disclosures.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from the commercial supporters of this program.
Disclosures of Educational Planner: Ambra King, PharmD (ASMSO) has no financial disclosures.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.